Here are 10 recent studies on gastroenterology and endoscopy-related issues.
GI & Endoscopy
Spectrum Pharmaceuticals has received approval from the U.S. Food and Drug Administration for the use of FUSILEV (levoleucovorin) in combination with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer, according to a company news release.
The FDA has released a draft guidance on properly cleaning and labeling reprocessed endoscopes to reduce the number of infections.
CT colonography polyp size is not significantly different from colonoscopy polyp size, according to research findings published in the journal Clinical Gastroenterology and Hepatology.
Marvin H. Sleisenger, MD, a gastroenterologist at the University of California at San Francisco, was honored with the UCSF Medal, the university's highest honor, according to a UCSF news release.
Researchers at Tufts University's School of Engineering have developed a device that could potentially reduce patient discomfort during routine colonoscopies while also ensuring the accuracy of the exam, according to a university news release.
Bariatric surgery is more effective than dieting for glucose control, according to a report in Science Translational Medicine.
Activation of the protein biomarker CTNNB1 in obese patients was associated with better survival from colorectal cancer and overall survival, according to a study in the Journal of the American Medical Association.
Patients who underwent cancer therapy during childhood are at increased risk of experiencing GI complications later in their lives, according to research published in the journal Gastroenterology.
A new study from the University of Michigan Comprehensive Cancer Center suggests a class of drugs that has shown promise for breast and ovarian cancer patients with BRCA gene mutations may also benefit certain colorectal cancer patients, according to a…
